Revised SPCs: Rifampicin containing products (Rifinah, Rifater, Rifadin)

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
14 February 2019

Abstract

SPCs updated to warn rifampicin may cause vitamin K dependent coagulopathy and severe bleeding. Monitoring of occurrence of coagulopathy is recommended for patients at particular bleeding risk.